EDMONTON, Alberta, June 13 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that it has completed the necessary documentation to apply for certification (CE status) of its VScan HIV test kits in Europe. As indicated in a March 29, 2006 press release, Medical Services agreed to a proposal from a European pharmaceutical company whereby they would pay the costs necessary, look after the submission of all data and complete any and all other procedures required to obtain certification of the VScan HIV test kit. The Company has now received all required documentation from Medical Services and has indicated that the application will be submitted to the appropriate authorities as soon as possible. It is our understanding that preliminary meetings have already taken place. Certification of the Vscan HIV test kit will allow the VScan HIV test kit to be sold in an additional 25 countries and should result in additional sales of up to $4,000,000 US per year. Preliminary marketing in several of these countries shows that there is significant demand for an HIV test kit that is accurate and easy to use using whole blood. Testing throughout the world by health departments continues to show that the VScan HIV test kit fits this criteria. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria, and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NDB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright